CMS Open Payments · Program Year 2024
SCA Pharmaceuticals, LLC
SCA Pharmaceuticals, LLC reported $806.08 in payments to 7 physicians and teaching hospitals across 7 transactions.
- $806.08
- Total payments
- 7
- Transactions
- 7
- Recipients
- −$5.5K
- General Payments vs PY2023
SCA Pharmaceuticals, LLC reported $806.08 in payments to 7 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1855 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $115.15 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
SCA Pharmaceuticals, LLC pairs modest payment volume with a moderately concentrated payment pattern.
- #1855
- of 1,925 companies
- 0.0%
- of all US industry payments
- 0.6%
- paid to its single top recipient
- 1
- payment categories
Release-over-release change
General Payments changed from PY2023 to PY2024
SCA Pharmaceuticals, LLC's CMS-reported General Payments decreased by $5.5K (−87.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.
CMS source labels for this exact identifier: PY2022: SCA PHARMACEUTICALS, LLCPY2023: SCA PHARMACEUTICALS, LLCPY2024: SCA Pharmaceuticals, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $6,279.33
- PY2024
- $806.08
How SCA Pharmaceuticals, LLC ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
SCA Pharmaceuticals, LLC's total vs. every reporting company
CMS Open Payments, Program Year 2024
$806 4th percentile higher than 4% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for SCA Pharmaceuticals, LLC
Averaging $115.15 per transaction and $115.15 per recipient, SCA Pharmaceuticals, LLC's Program Year 2024 total comes to $806.08 across 7 transactions and 7 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1855 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Food and Beverage" leads the 1-category general-payment breakdown below at $806.08 (100.0% of the company's reported total, 7 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Food and Beverage" leads SCA Pharmaceuticals, LLC's 1-category general-payment breakdown at $806.08, 100.0% of the reported total.
How SCA Pharmaceuticals, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $806.08 | 7 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $806.08 (100.0%) of $806.08 in this company's General Payments records across 5 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for SCA Pharmaceuticals, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Nyu Langone Hospitals
$466.71 across 3 reported transactions
- 2
Ronald Reagan UCLA
$128.76 across 1 reported transactions
- 3
Montefiore Medical Center
$83.60 across 1 reported transactions
- 4
Westchester Medical Center
$83.60 across 1 reported transactions
- 5
Umass Memorial Medical Center
$43.41 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Payment Size Analysis
Average transaction size: $115.15. Average per recipient: $115.15.
Total Amount
$806.08
Avg per Transaction
$115.15
Avg per Recipient
$115.15
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
SCA Pharmaceuticals, LLC Share
0.0%
#1855 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to SCA Pharmaceuticals, LLC
Frequently Asked Questions
How much did SCA Pharmaceuticals, LLC pay to physicians and hospitals in 2024? ▾
How many physicians received payments from SCA Pharmaceuticals, LLC? ▾
What types of payments did SCA Pharmaceuticals, LLC make? ▾
How does SCA Pharmaceuticals, LLC rank among pharmaceutical companies? ▾
What is the average payment size from SCA Pharmaceuticals, LLC? ▾
Where does the payment data for SCA Pharmaceuticals, LLC come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.